Statins decrease fibrosis and lower portal hypertension in animals and humans mainly by blunting the RhoA/Rho-kinase-pathway in myofibroblastic HSCs9, 10, 11, 12, 13, 14, 15, 16. The gene discussed is RHOA; the disease is portal hypertension.